Research Site 32 — Oklahoma City, Oklahoma

Research Site 32 is a clinical research site located in Oklahoma City, Oklahoma, United States 73112.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Research Site 32 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Severe Hypertriglyceridemia.

Sponsors: Arrowhead Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Research Site 32?

Research Site 32 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Research Site 32 conducted?

Research Site 32 has 1 clinical trials on record, with 1 currently active. Their work covers Severe Hypertriglyceridemia.

Is Research Site 32 accredited by Crixeo Health?

Research Site 32 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Research Site 32?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.